Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Influence of Climate on Radial Growth of Black Pine on the Mountain Regions of Southwestern Turkey.

Doğan M, Köse N.

Plants (Basel). 2019 Aug 9;8(8). pii: E276. doi: 10.3390/plants8080276.

2.

A lipid-encapsulated mRNA encoding a potently neutralizing human monoclonal antibody protects against chikungunya infection.

Kose N, Fox JM, Sapparapu G, Bombardi R, Tennekoon RN, de Silva AD, Elbashir SM, Theisen MA, Humphris-Narayanan E, Ciaramella G, Himansu S, Diamond MS, Crowe JE Jr.

Sci Immunol. 2019 May 17;4(35). pii: eaaw6647. doi: 10.1126/sciimmunol.aaw6647.

PMID:
31101672
3.

A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.

Bangaru S, Lang S, Schotsaert M, Vanderven HA, Zhu X, Kose N, Bombardi R, Finn JA, Kent SJ, Gilchuk P, Gilchuk I, Turner HL, García-Sastre A, Li S, Ward AB, Wilson IA, Crowe JE Jr.

Cell. 2019 May 16;177(5):1136-1152.e18. doi: 10.1016/j.cell.2019.04.011.

PMID:
31100268
4.

Do Stabilization Exercises Increase the Effects of Lumbar Facet Radiofrequency Denervation?

Cetin H, Kose N, Turkmen C, Dulger E, Bilgin S, Sahin A.

Turk Neurosurg. 2019;29(4):576-583. doi: 10.5137/1019-5149.JTN.24946-18.2.

5.

Associations between risk factors and developmental dysplasia of the hip and ultrasonographic hip type: a retrospective case control study.

Ömeroğlu H, Akceylan A, Köse N.

J Child Orthop. 2019 Apr 1;13(2):161-166. doi: 10.1302/1863-2548.13.180174.

6.

The association between the lymphocyte-to-monocyte ratio and coronary artery disease severity in patients with stable coronary artery disease.

Kose N, Akin F, Yildirim T, Ergun G, Altun I.

Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2570-2575. doi: 10.26355/eurrev_201903_17406.

7.

High frequency of shared clonotypes in human B cell receptor repertoires.

Soto C, Bombardi RG, Branchizio A, Kose N, Matta P, Sevy AM, Sinkovits RS, Gilchuk P, Finn JA, Crowe JE Jr.

Nature. 2019 Feb;566(7744):398-402. doi: 10.1038/s41586-019-0934-8. Epub 2019 Feb 13.

PMID:
30760926
8.

Early Human B Cell Response to Ebola Virus in Four U.S. Survivors of Infection.

Williamson LE, Flyak AI, Kose N, Bombardi R, Branchizio A, Reddy S, Davidson E, Doranz BJ, Fusco ML, Saphire EO, Halfmann PJ, Kawaoka Y, Piper AE, Glass PJ, Crowe JE Jr.

J Virol. 2019 Apr 3;93(8). pii: e01439-18. doi: 10.1128/JVI.01439-18. Print 2019 Apr 15.

PMID:
30728263
9.

Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.

Chukwuma VU, Kose N, Sather DN, Sapparapu G, Falk R, King H, Singh V, Lampley R, Malherbe DC, Ditto NT, Sullivan JT, Barnes T, Doranz BJ, Labranche CC, Montefiori DC, Kalams SA, Haigwood NL, Crowe JE Jr.

PLoS One. 2018 Dec 19;13(12):e0209437. doi: 10.1371/journal.pone.0209437. eCollection 2018.

10.

Human mAbs to Staphylococcus aureus IsdA Provide Protection Through Both Heme-Blocking and Fc-Mediated Mechanisms.

Bennett MR, Bombardi RG, Kose N, Parrish EH, Nagel MB, Petit RA, Read TD, Schey KL, Thomsen IP, Skaar EP, Crowe JE.

J Infect Dis. 2019 Apr 8;219(8):1264-1273. doi: 10.1093/infdis/jiy635.

PMID:
30496483
11.

A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.

Goo L, Debbink K, Kose N, Sapparapu G, Doyle MP, Wessel AW, Richner JM, Burgomaster KE, Larman BC, Dowd KA, Diamond MS, Crowe JE Jr, Pierson TC.

Nat Microbiol. 2019 Jan;4(1):71-77. doi: 10.1038/s41564-018-0283-7. Epub 2018 Nov 19.

12.

Hip and Knee Section, Prevention, Prosthesis Factors: Proceedings of International Consensus on Orthopedic Infections.

Aboltins CA, Antoci V, Bhattacharyya S, Cross M, Ducheyne P, Freiberg AA, Hailer N, Kay P, Ketonis C, Klement MR, Köse N, Lee M, Mitchell P, Nandi S, Palacio JC, Perry K, Prieto H, Shahi A, Trebše R, Turner D, Wu CT, Yazdi H.

J Arthroplasty. 2019 Feb;34(2S):S309-S320. doi: 10.1016/j.arth.2018.09.016. Epub 2018 Oct 19. No abstract available.

PMID:
30348551
13.

Prison Suicide in Comparison to Suicide Events in Forensic Psychiatric Hospitals in Germany.

Voulgaris A, Kose N, Konrad N, Opitz-Welke A.

Front Psychiatry. 2018 Aug 28;9:398. doi: 10.3389/fpsyt.2018.00398. eCollection 2018.

14.

Human Monoclonal Antibodies That Neutralize Pandemic GII.4 Noroviruses.

Alvarado G, Ettayebi K, Atmar RL, Bombardi RG, Kose N, Estes MK, Crowe JE Jr.

Gastroenterology. 2018 Dec;155(6):1898-1907. doi: 10.1053/j.gastro.2018.08.039. Epub 2018 Aug 28.

PMID:
30170116
15.

Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein.

Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, Flinko R, Orlandi C, Carnahan R, Parrish EH, Sevy AM, Bombardi RG, Singh PK, Mukadi P, Muyembe-Tamfum JJ, Ohi MD, Saphire EO, Lewis GK, Alter G, Ward AB, Rimoin AW, Bukreyev A, Crowe JE Jr.

Immunity. 2018 Aug 21;49(2):363-374.e10. doi: 10.1016/j.immuni.2018.06.018. Epub 2018 Jul 17.

16.

A comparison of the acute effects of radial extracorporeal shockwave therapy, ultrasound therapy, and exercise therapy in plantar fasciitis.

Akınoğlu B, Köse N.

J Exerc Rehabil. 2018 Apr 26;14(2):306-312. doi: 10.12965/jer.1836048.024. eCollection 2018 Apr.

17.

Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region.

Flyak AI, Kuzmina N, Murin CD, Bryan C, Davidson E, Gilchuk P, Gulka CP, Ilinykh PA, Shen X, Huang K, Ramanathan P, Turner H, Fusco ML, Lampley R, Kose N, King H, Sapparapu G, Doranz BJ, Ksiazek TG, Wright DW, Saphire EO, Ward AB, Bukreyev A, Crowe JE Jr.

Nat Microbiol. 2018 Jun;3(6):670-677. doi: 10.1038/s41564-018-0157-z. Epub 2018 May 7.

18.

Mouse and Human Monoclonal Antibodies Protect against Infection by Multiple Genotypes of Japanese Encephalitis Virus.

Fernandez E, Kose N, Edeling MA, Adhikari J, Sapparapu G, Lazarte SM, Nelson CA, Govero J, Gross ML, Fremont DH, Crowe JE Jr, Diamond MS.

MBio. 2018 Feb 27;9(1). pii: e00008-18. doi: 10.1128/mBio.00008-18.

19.

The effect of stabilization exercises on diaphragm muscle thickness and movement in women with low back pain.

Dülger E, Bilgin S, Bulut E, İnal İnce D, Köse N, Türkmen C, Çetin H, Karakaya J.

J Back Musculoskelet Rehabil. 2018;31(2):323-329. doi: 10.3233/BMR-169749.

PMID:
29278870
20.

A comparison of occupational groups using different working postures in terms of their low back and neck health status.

Cetin H, Bilgin S, Köse N.

J Back Musculoskelet Rehabil. 2018;31(3):475-480. doi: 10.3233/BMR-170814.

PMID:
29171981
21.

Comparison of the Acute Effect of Radial Shock Wave Therapy and Ultrasound Therapy in the Treatment of Plantar Fasciitis: A Randomized Controlled Study.

Akinoglu B, Köse N, Kirdi N, Yakut Y.

Pain Med. 2017 Dec 1;18(12):2443-2452. doi: 10.1093/pm/pnx113.

PMID:
28575496
22.

Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance.

Bailey JR, Flyak AI, Cohen VJ, Li H, Wasilewski LN, Snider AE, Wang S, Learn GH, Kose N, Loerinc L, Lampley R, Cox AL, Pfaff JM, Doranz BJ, Shaw GM, Ray SC, Crowe JE Jr.

JCI Insight. 2017 May 4;2(9). pii: 92872. doi: 10.1172/jci.insight.92872. eCollection 2017 May 4.

23.

Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE Jr.

J Infect Dis. 2017 Apr 1;215(7):1124-1131. doi: 10.1093/infdis/jix071.

24.

A novel pre-fusion conformation-specific neutralizing epitope on the respiratory syncytial virus fusion protein.

Mousa JJ, Kose N, Matta P, Gilchuk P, Crowe JE Jr.

Nat Microbiol. 2017 Jan 30;2:16271. doi: 10.1038/nmicrobiol.2016.271.

25.

Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to Dengue Virus Serotype 4 Infection and Vaccination.

Nivarthi UK, Kose N, Sapparapu G, Widman D, Gallichotte E, Pfaff JM, Doranz BJ, Weiskopf D, Sette A, Durbin AP, Whitehead SS, Baric R, Crowe JE Jr, de Silva AM.

J Virol. 2017 Feb 14;91(5). pii: e02041-16. doi: 10.1128/JVI.02041-16. Print 2017 Mar 1.

26.

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.

Sapparapu G, Fernandez E, Kose N, Bin Cao, Fox JM, Bombardi RG, Zhao H, Nelson CA, Bryan AL, Barnes T, Davidson E, Mysorekar IU, Fremont DH, Doranz BJ, Diamond MS, Crowe JE.

Nature. 2016 Dec 15;540(7633):443-447. doi: 10.1038/nature20564. Epub 2016 Nov 7.

27.

Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus Infections.

Gilchuk I, Gilchuk P, Sapparapu G, Lampley R, Singh V, Kose N, Blum DL, Hughes LJ, Satheshkumar PS, Townsend MB, Kondas AV, Reed Z, Weiner Z, Olson VA, Hammarlund E, Raue HP, Slifka MK, Slaughter JC, Graham BS, Edwards KM, Eisenberg RJ, Cohen GH, Joyce S, Crowe JE Jr.

Cell. 2016 Oct 20;167(3):684-694.e9. doi: 10.1016/j.cell.2016.09.049.

28.

A 200-year reconstruction of Kocasu River (Sakarya River Basin, Turkey) streamflow derived from a tree-ring network.

Güner HT, Köse N, Harley GL.

Int J Biometeorol. 2017 Mar;61(3):427-437. doi: 10.1007/s00484-016-1223-y. Epub 2016 Aug 30.

PMID:
27577030
29.

Recognition of influenza H3N2 variant virus by human neutralizing antibodies.

Bangaru S, Nieusma T, Kose N, Thornburg NJ, Finn JA, Kaplan BS, King HG, Singh V, Lampley RM, Sapparapu G, Cisneros A 3rd, Edwards KM, Slaughter JC, Edupuganti S, Lai L, Richt JA, Webby RJ, Ward AB, Crowe JE Jr.

JCI Insight. 2016 Jul 7;1(10). pii: e86673.

30.

Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.

Demir Ö, Köse N, Özkan E, Ünlütürk U, Aras G, Erdoğan MF.

Nucl Med Commun. 2016 Jul;37(7):715-20. doi: 10.1097/MNM.0000000000000495.

PMID:
26963467
31.

H7N9 influenza virus neutralizing antibodies that possess few somatic mutations.

Thornburg NJ, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley RM, Bombardi RG, Yu Y, Graham S, Branchizio A, Yoder SM, Rock MT, Creech CB, Edwards KM, Lee D, Li S, Wilson IA, García-Sastre A, Albrecht RA, Crowe JE Jr.

J Clin Invest. 2016 Apr 1;126(4):1482-94. doi: 10.1172/JCI85317. Epub 2016 Mar 7.

32.

Stent diameter and type matters in the decision of 6 FR or 7 FR guiding catheter selection during simultaneous kissing stent technique in bifurcation lesions.

Kırat T, Köse N, Altun İ, Akın F, Ergün G, Soylu MÖ.

Int J Cardiol. 2016 Oct 15;221:1151-2. doi: 10.1016/j.ijcard.2016.01.086. Epub 2016 Feb 10. No abstract available.

PMID:
26874997
33.

Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection.

Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, Lampley R, Kose N, Ilinykh PA, Kuzmina N, Branchizio A, King H, Brown L, Bryan C, Davidson E, Doranz BJ, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Saphire EO, Ward AB, Bukreyev A, Crowe JE Jr.

Cell. 2016 Jan 28;164(3):392-405. doi: 10.1016/j.cell.2015.12.022. Epub 2016 Jan 21.

34.

What is the role of routine ECG screening in stable coronary heart disease and effects of oral anticoagulant, antiarrhythmics in these patients with atrial fibrillation?

Kırat T, Köse N, Altun İ, Akın F, Ergün G, Soylu MÖ.

Int J Cardiol. 2016 Mar 15;207:140. doi: 10.1016/j.ijcard.2016.01.078. Epub 2016 Jan 9. No abstract available.

PMID:
26802816
35.

The steeper PR interval/HR slope is better in patients with long PR interval during stress test.

Kırat T, Köse N, Altun İ, Akın F, Ergün G, Soylu MÖ.

Int J Cardiol. 2016 Oct 15;221:1150. doi: 10.1016/j.ijcard.2015.11.094. Epub 2015 Nov 18. No abstract available.

PMID:
26640120
36.

Old World megadroughts and pluvials during the Common Era.

Cook ER, Seager R, Kushnir Y, Briffa KR, Büntgen U, Frank D, Krusic PJ, Tegel W, van der Schrier G, Andreu-Hayles L, Baillie M, Baittinger C, Bleicher N, Bonde N, Brown D, Carrer M, Cooper R, Čufar K, Dittmar C, Esper J, Griggs C, Gunnarson B, Günther B, Gutierrez E, Haneca K, Helama S, Herzig F, Heussner KU, Hofmann J, Janda P, Kontic R, Köse N, Kyncl T, Levanič T, Linderholm H, Manning S, Melvin TM, Miles D, Neuwirth B, Nicolussi K, Nola P, Panayotov M, Popa I, Rothe A, Seftigen K, Seim A, Svarva H, Svoboda M, Thun T, Timonen M, Touchan R, Trotsiuk V, Trouet V, Walder F, Ważny T, Wilson R, Zang C.

Sci Adv. 2015 Nov 6;1(10):e1500561. doi: 10.1126/sciadv.1500561. eCollection 2015 Nov.

37.

Silver ion doped ceramic nano-powder coated nails prevent infection in open fractures: In vivo study.

Kose N, Çaylak R, Pekşen C, Kiremitçi A, Burukoglu D, Koparal S, Doğan A.

Injury. 2016 Feb;47(2):320-4. doi: 10.1016/j.injury.2015.10.006. Epub 2015 Oct 21.

PMID:
26589596
38.

What is the most possible cause of the side branch occlusion after bioabsorbable everolimus-eluting stent implantation?: Thickness of the scaffolds or large plaque burden?

Kırat T, Köse N, Altun İ, Akın F, Ergün G, Soylu MÖ.

Int J Cardiol. 2016 Apr 15;209:348. doi: 10.1016/j.ijcard.2015.10.244. Epub 2015 Nov 10. No abstract available.

PMID:
26558339
39.

Predictors of slow flow in angiographically normal coronary arteries.

Altun I, Akin F, Kose N, Sahin C, Kirli I.

Int J Clin Exp Med. 2015 Aug 15;8(8):13762-8. eCollection 2015.

40.

The effects of parasympatholytic and sympatheticomimetic nebulization therapy in gradient increase in the left ventricular outflow tract: Do they have the same influence?

Kırat T, Köse N, Altun İ, Akın F, Soylu MÖ.

Int J Cardiol. 2016 Jan 15;203:1138-9. doi: 10.1016/j.ijcard.2015.10.153. Epub 2015 Oct 20. No abstract available.

PMID:
26515255
41.

Dengue Virus prM-Specific Human Monoclonal Antibodies with Virus Replication-Enhancing Properties Recognize a Single Immunodominant Antigenic Site.

Smith SA, Nivarthi UK, de Alwis R, Kose N, Sapparapu G, Bombardi R, Kahle KM, Pfaff JM, Lieberman S, Doranz BJ, de Silva AM, Crowe JE Jr.

J Virol. 2015 Oct 28;90(2):780-9. doi: 10.1128/JVI.01805-15. Print 2016 Jan 15.

42.

Possible causes of the gradient decrease in the right ventricular outflow tract in biventricular hypertrophic cardiomyopathy.

Kırat T, Köse N, Altun İ, Akın F, Soylu MÖ.

Int J Cardiol. 2016 Apr 15;209:349. doi: 10.1016/j.ijcard.2015.10.055. Epub 2015 Oct 8. No abstract available.

PMID:
26476969
43.

Training Medical Specialists to Communicate Better with Patients with Medically Unexplained Physical Symptoms (MUPS). A Randomized, Controlled Trial.

Weiland A, Blankenstein AH, Van Saase JL, Van der Molen HT, Jacobs ME, Abels DC, Köse N, Van Dulmen S, Vernhout RM, Arends LR.

PLoS One. 2015 Sep 18;10(9):e0138342. doi: 10.1371/journal.pone.0138342. eCollection 2015.

44.

Analyses of the modulatory effects of antibacterial silver doped calcium phosphate-based ceramic nano-powder on proliferation, survival, and angiogenic capacity of different mammalian cells in vitro.

Bostancıoğlu RB, Peksen C, Genc H, Gürbüz M, Karel FB, Koparal AS, Dogan A, Kose N, Koparal AT.

Biomed Mater. 2015 Aug 26;10(4):045024. doi: 10.1088/1748-6041/10/4/045024.

PMID:
26306474
45.

Relation of platelet indices to severity of coronary artery disease in patients undergoing primary percutaneous coronary intervention.

Akin F, Ayca B, Kose N, Altun I, Avsar M, Celik O, Satilmis S, Eksik A, Okuyan E.

Perfusion. 2016 Apr;31(3):216-22. doi: 10.1177/0267659115594231. Epub 2015 Jul 15.

PMID:
26178072
46.

Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.

Smith SA, Silva LA, Fox JM, Flyak AI, Kose N, Sapparapu G, Khomandiak S, Ashbrook AW, Kahle KM, Fong RH, Swayne S, Doranz BJ, McGee CE, Heise MT, Pal P, Brien JD, Austin SK, Diamond MS, Dermody TS, Crowe JE Jr.

Cell Host Microbe. 2015 Jul 8;18(1):86-95. doi: 10.1016/j.chom.2015.06.009. Erratum in: Cell Host Microbe. 2015 Sep 9;18(3):382. Khomadiak, Solomiia [corrected to Khomandiak, Solomiia].

47.

Hematologic parameters in patients with sarcoidosis.

Kalemci S, Akin F, Altun I, Kose N.

Clin Respir J. 2017 May;11(3):399. doi: 10.1111/crj.12342. Epub 2015 Jul 14. No abstract available.

PMID:
26084615
48.

Targeted delivery of interleukin-10 to chronic cardiac allograft rejection using a human antibody specific to the extra domain A of fibronectin.

Franz M, Doll F, Grün K, Richter P, Köse N, Ziffels B, Schubert H, Figulla HR, Jung C, Gummert J, Renner A, Neri D, Berndt A.

Int J Cardiol. 2015 Sep 15;195:311-22. doi: 10.1016/j.ijcard.2015.05.144. Epub 2015 May 29.

PMID:
26056964
49.

Success of Pavlik Harness Treatment Decreases in Patients ≥ 4 Months and in Ultrasonographically Dislocated Hips in Developmental Dysplasia of the Hip.

Ömeroğlu H, Köse N, Akceylan A.

Clin Orthop Relat Res. 2016 May;474(5):1146-52. doi: 10.1007/s11999-015-4388-5.

50.

The thrombogenic potential of contrast media and thrombotic complications after coronary angiography.

Kırat T, Köse N, Altun İ, Akın F.

Int J Cardiol. 2015 Sep 1;194:1. doi: 10.1016/j.ijcard.2015.05.114. Epub 2015 May 20. No abstract available.

PMID:
26005210

Supplemental Content

Support Center